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We have isolated an SV40 transformation revertant cell line, CL1 L, by selection for normal cells whose growth is 
inhibited under low serum conditions. This line expresses a single, wild-type copy of large T antigen, yet is not trans- 
formed. It is not retransformable by transfection of SV40 DNA or infection with a recombinant retrovirus encoding large 
T antigen. Resistance to transformation therefore appears to be due to a cellular mutation. Fusion of CL1 L cells to 
normal 3T3 cells or SV40-transformed cells results in somatic cell hybrids that are transformed, indicating that resis- 
tance is recessive. In addition, fusion of CL1 L cells to another SV40 transformation-resistant line, A27, results in 
transformed hybrids, indicating the existence of discrete complementation groups with respect to SV40 
transformation. 0 1992 Academic Press, Inc. 
INTRODUCTION 
The disruption of normal cell growth control by SV40 
large T antigen requires the interaction of T antigen 
with proteins which normally regulate cell growth and 
division. Although some of these proteins, such as 
~53, pRb, and plO7/pl20 (referred to herein as pl20), 
have been identified and their genes cloned and char- 
acterized (Linzer and Levine, 1979; Lane and Craw- 
ford, 1979; DeCaprio et al., 1988; Ewen et al., 1989; 
Dyson et a/., 1989), they alone cannot account for 
large T antigen’s transforming ability. For example, 
some mutant T antigens which still bind these proteins 
are defective for transformation (Rutila et al., 1986; 
Manfredi and Prives, 1990; Yaciuk et al,, 1991), and 
mutants which do not bind these proteins can some- 
times still transform (Srinivasan eta/., 1989; Tack eta/., 
1989; Ludlow et a/., 1990). Thus, at least one more 
host function must be involved in transformation. Addi- 
tionally, one would like to know what steps beyond 
binding of T antigen to host proteins lead to the trans- 
formed state. 
All of the proteins mentioned above were recognized 
by their presence in immunoprecipitates of T antigen. 
While such biochemical analysis of T antigen com- 
plexes is a powerful approach toward identifying such 
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factors, it can be limited in that it only allows detection 
of proteins which are stably associated with T antigen. 
Proteins which interact with T antigen on a transient 
basis and proteins which act downstream of those ac- 
tually bound to T antigen probably escape detection in 
these assays. 
In attempts to identify these types of factors, a num- 
ber of laboratories, including ours, have taken genetic 
approaches toward the study of transformation by T 
antigen. Specifically, we have been interested in isolat- 
ing murine cell lines which are resistant to transforma- 
tion by large T antigen. Such cell lines presumably con- 
tain a cellular mutation which renders them resistant. 
One such line, A27, was isolated by introducing T anti- 
gen into 3T3 fibroblasts under nonselective conditions 
and screening for cells that express T antigen but are 
not transformed (Ryan et al., 1985). Another genetic 
approach involves the isolation of transformation re- 
vertants, derivatives of transformed cell lines which ap- 
pear to be normal due to host mutations (Vogel et al., 
1973; Maruyama et al., 1982; Bauer et a/., 1987). In 
this report, we describe the isolation and characteriza- 
tion of one such revertant cell line, CL1 L. CL1 L cells 
express a functional T antigen (T+), are transformation 
negative (tr-), and are specifically resistant to retrans- 
formation by SV40. Fusion of CLlL to normal and 
transformed cells indicates that the defect in CL1 L is 
recessive. Of particular interest, fusion of CL1 L to A27 
yields transformed cells, indicating the existence of at 
least two complementation groups with respect to 
SV40 transformation susceptibility. 
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MATERIALS AND METHODS 
Cell lines 
All cell lines except retrovirus producer lines were 
maintained in minimal Eagle’s medium (MA Bioprod- 
ucts) supplemented with 0.2 mg/ml NaHCO,, 0.29 
mg/ml glutamine, 100 units/ml penicillin, and 100 ygl 
ml streptomycin. Transformed and revertant cells were 
maintained in 10% fetal calf serum (MEM-10); and 
BALB/c 3T3 cells in 20% fetal calf serum (MEM-20). 
Retrovirus producer cell lines (Brown et al., 1986) were 
maintained in Dulbecco’s modified Eagle’s medium 
(GIBCO) supplemented with 100 units/ml penicillin, 
100 pg/ml streptomycin, and 10% calf serum (DMEM- 
10). .The transfer of dominant selectable markers into 
cells for use in fusion experiments was carried out by 
transfection of pSV2neo (Southern and Berg, 1982) or 
pY3 (Blochlinger and Diggelmann, 1984) followed by 
selection in 400 to 600 pg/ml G418 (GIBCO) or 300 
pg/ml hygromycin B (CalBiochem), respectively. Well- 
isolated, drug-resistant colonies were picked and sub- 
cloned by end point dilution. 
Isolation of revertants 
To isolate serum revertants, A209Rl Bl cells were 
plated on Day 0 at a density of 1 X 1 O4 cells/cm2 in 
MEM-10. On Day 1 the medium was changed to 
MEM-1, and on Day 2 one of two drugs was added: 
200 pg/ml fluorodeoxyuridine (FUdR) in the presence of 
2 mg/ml uridine, or 1 pg/ml colchicine. Excess uridine 
was added during FUdR treatment to prevent the incor- 
poration of FUdR into RNA. After a 6-day exposure to 
the drugs, cells were trypsinized and plated in MEM- 
10. Surviving colonies were subcloned by limiting dilu- 
tion. To isolate density revertants, A209Rl Bl cells 
were plated on Day 0 at a density of 6 X 1 O4 cells/cm2 
and exposed to drugs for 3 days. 
Transfections 
Calcium phosphate-DNA precipitates were made 
and added to cells as previously described (Imperiale 
et al., 1983). Approximately 18 to 24 hr later the me- 
dium containing the precipitate was removed and the 
cells were fed with MEM-10. After an additional 24 hr, 
cells were split into assays as described under Results. 
Transformation and growth assays 
Monolayer overgrowth assays, measurements of 
cell growth in 10% FCS and 1% FCS, and focus forma- 
tion assays were performed as described (Brockman, 
1978; Christensen and Brockman, 1982). Assay 
dishes were stained with 0.1 o/o Wright’s stain in metha- 
nol. Soft agar assays were carried out as described 
previously (Brockman, 1978; Christensen and Brock- 
man, 1982) with the following modifications. Assays 
on the original 56 candidate revertant cell lines were 
performed in low-melting-point agarose (LMPA), which 
was used at a concentration of 0.625% in the base 
layer and 0.412% in the cell overlay layer. The assays 
were fed weekly with overlay mixture, and the dishes 
were scored after 2 weeks. All subsequent assays 
used low EEO agarose (Boehringer-Mannheim) at 
0.5% in the base layer and 0.33% in the cell overlay 
layer. These assays were fed weekly with overlay mix- 
ture and scored after 5 weeks. Colonies were scored 
positive if they were 20.01 inches in diameter. 
Southern blots 
Southern blots were performed using 0.8% agarose 
gels as previously described (Bender and Brockman, 
1981). 
Plasmid DNA preparation 
Plasmid DNA was prepared by standard methods 
(Maniatis et al., 1982). 
Retroviral infections 
Twelve hours prior to infection the producer cells, at 
80% confluence, were fed fresh DMEM-10. The day of 
the infection, the medium from the producer lines was 
collected, polybrene was added at 8 pg/ml, and the 
mixture was passed through a 0.45-pm low-protein- 
binding filter. Cells at approximately 50% confluence 
were infected with 2 ml of the harvested retroviral me- 
dium for 2 hr at 37” with gentle rocking every 20 min. 
The dishes were then fed with 8 ml of MEM-10, moved 
to 33”, incubated for 2 days, and split into assays. 
Infected cells (l/l000 or l/500) were plated into 60- 
mm dishes in 500 pg/ml G418 to determine the effi- 
ciency of the retroviral infection. Cells to be assayed for 
transformation were split either l/l 00 or l/50 from the 
infected dish into loo-mm dishes and grown in MEM- 
10 plus 500 yglml G418. After 2 weeks these cells 
were placed into soft agar assays, picked to establish 
clonal cell lines, or used for immunoprecipitations. The 
remainder of the original dish of infected cells was 
placed directly into focus or 1% serum assays. 
Cell fusions 
The day before the fusion, equal numbers of cells 
from both parental lines were plated into each of three 
1 O-cm’ wells in MEM-10 at 37”. Fusion was carried 
out the next day, when the cell monolayers had 
reached confluence. Medium was removed and the 
cells were exposed to 1 ml of 50% 2~ MEM, 5% FCS, 
SV40 TRANSFORMATION COMPLEMENTATION GROUPS 725 
0.3 mg/ml glutamine, 100 units/ml penicillin, 100 pg/ml 
streptomycin, and 50% (v/v) polyethylene glycol 600 
(Sigma) for 40 set followed by rapid dilution with 4 ml 
MEM-5. The cells were then washed four times with 2 
ml MEM-5, fed with MEM-10, and moved to 33”. 
Twenty-four hours later the cells were fed with fresh 
MEM-10. The next day cells from the three wells were 
trypsinized, pooled, and plated into two 1 50-cm2 flasks 
in MEM-10. The following day selection was started 
with 450 pg/ml G418 and 300 pg/ml hygromycin B. 
Equal numbers of surviving colonies were pooled and 
placed into transformation assays. 
lmmunoprecipitation analysis 
Confluent loo-mm dishes of cells were washed 
once with DMEM without methionine (DMEM met-) 
and fed with 5 ml of labeling medium (100/o FCS, 10% 
DMEM, and 80% DMEM met-) containing 35S-labeled 
methionine and cysteine (Translabel, ICN Radiochemi- 
cals) at 60 &i/ml. Cells were labeled at 37” for 23 hr. 
After labeling, the cells were washed twice with ice- 
cold PBS and lysed at 4” for 30 min in 1 ml lysis buffer 
(250 mM NaCI, 0.1% NP-40, 50 mM HEPES, pH 7.0) 
(Whyte er al., 1988) containing 5 pg/ml each of PMSF, 
leupeptin, and aprotinin. The lysates were cleared by 
centrifugation at 16,000 g for 2 min and stored at 
-70”. lmmunoprecipitations were carried out over- 
night at 4” in 0.5-ml reactions containing 250 yl lysate, 
250 ~1 lysis buffer, and excess antibody. Complexes 
were recovered by incubating with 150 ~1 of 6% CL-4B 
protein A-Sepharose (Pharmacia) in lysis buffer for 30 
min, with rocking. Samples were washed five times 
with 1 ml lysis buffer, and immunoprecipitated proteins 
were released by boiling and separated by electropho- 
resis through 8% SDS-polyacrylamide discontinuous 
gels (Laemmli, 1970). Gels were fixed for 30 min in 
30% methanol, 10% acetic acid and then treated with 
Amplify (Amersham) for 30 min. After drying under vac- 
uum at 80”, the gels were exposed to Kodak XAR film 
at -70”. 
RESULTS 
Generation and characterization of SV40 revertants 
In order to increase the chances of obtaining rever- 
tants due to mutations in cellular genes, we chose a 
parental transformed cell line containing multiple cop- 
ies of the SV40 early region. Use of such a parental line 
would be expected to lower the frequency of reversion 
resulting from loss of T antigen coding regions. This 
line, A209Rl Bl, is an SV40-transformed BALB/c 3T3 
line that expresses at least two distinct transformation- 
competent large T antigens (Brockman, 1978; Bender 
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a Efficiency of plating is the number of colonies/number of cells 
seeded into the assay. 
et al., 1983). To isolate revertants, A209Rl Bl cells 
were subjected to the negative selection protocols dis- 
cussed under Materials and Methods. These condi- 
tions allow for growth of transformed cells, which are 
then selectively killed by the cytotoxic drugs colchicine 
or FUdR. Colchicine disrupts microtubule polymeriza- 
tion and kills cells by inhibiting cytokinesis (Borisy and 
Taylor, 1967) and is more toxic to SV40-transformed 
cells than normal cells (Vogel et al., 1973). FUdR pre- 
vents thymidine synthesis by inhibiting thymidylate syn- 
thetase (Rueckert and Mueller, 1960). Two different 
selection protocols were employed with each drug in 
an effort to generate revertants caused by distinct cel- 
lular alterations: cells plated at high density in normal 
concentrations of serum, or low density in low serum, 
were selected with each drug. 
Fifty-six potential revertant cell lines were isolated 
using the four variations of the selection scheme. This 
represents a reversion frequency of about 1 X 10w5, 
which is within the range reported by others (Culp and 
Black, 1972; Vogel and Pollack, 1973). These cell lines 
were screened for the presence of large T antigen by 
indirect immunofluorescence, the ability to overgrow 
preformed monolayers of BALB/c 3T3 cells, and 
growth in LMPA. Six cell lines had the desired pheno- 
type, T+/tr-. These fell into two classes: colchicine 
serum revertants, designated CL (Colchicine, Low 
density), and FUdR density revertants, designated FH 
(FUdR, High density) (Table 1). All six produce large T 
antigen which localizes to the nucleus. Five exhibit at 
least partial reversion in both growth parameters. 
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FH2B, however, fails to form colonies on preformed 
monolayers, yet grows as well as A209Rl Bl in LMPA. 
To examine the integrity of the early region se- 
quences in the revertant lines, cellular DNA from these 
lines and A209Rl Bl was digested with Hpall and 
BarnHI, enzymes which separate the early region of the 
SV40 genome from the late region, and analyzed by 
Southern blotting using a probe that consists of the 
entire SV40 genome. The results from four of the cell 
lines are shown in Fig. 1A. CLlE, CLlF, CLlL, and 
FH 1 B all contain an intact SV40 early region, as indi- 
cated by a diagnostic band of 3056 nucleotides. All of 
these cell lines therefore contain early region se- 
quences that are capable of encoding a wild-type size 
T antigen. The large T antigen produced by the six cell 
lines was examined by immunoprecipitation of 
[35S]methionine-labeled proteins with hamster anti- 
SV40 tumor serum (Fig. 1B). All six lines produce a 
large T antigen of 94 kDa, the same size as wild-type T 
antigen. The cellular protein p53 coimmunoprecipi- 
tates with T antigen in all the revertant lines. This analy- 
sis suggests that there is no gross alteration of the T 
antigens produced by these six cell lines. 
Retransformation with wild-type T antigen 
Even though the large T antigens expressed by 
these lines appear to be wild type, viral mutations 
could inactivate the transforming ability of T antigen 
without altering its size, association with ~53, or sub- 
cellular localization. To test whether these cell lines are 
true cellular revertants, we asked whether they could 
be retransformed by introducing a wild-type copy of 
large T antigen. The revertants were cotransfected 
with a plasmid encoding T antigen, pSVB3, and a plas- 
mid encoding a selectable marker, pSV2neo, at a 10: 1 
ratio and assayed for the ability to overgrow preformed 
3T3 monolayers. Cells that survived selection in G418 
were plated into transformation assays. A plasmid en- 
coding an activated c-Ha-ras gene, pEJ6.6 (Shih and 
Weinberg, 1982), was transfected independently to 
ascertain the specificity of transformation resistance of 
the revertants and to ask whether they are capable of 
exhibiting the transformed phenotype. The FH2K cell 
line was difficult to transfect and was dropped from the 
study. CLIF, FHl B, and FH2B were retransformed byT 
antigen, but CL1 L and CL1 E were not (Table 2). The 
efficiency of transfection of all the cell lines was the 
same, so differences in DNA uptake cannot explain the 
results. In addition, all of the cell lines were trans- 
formed by ras. CL1 Land CL1 E were next tested for the 
ability to be retransformed in a focus formation assay. 
Cells were cotransfected with pSV2neo and either 
pSVB3 or pEJ6.6 and assayed for focus formation. 
Both lines were transformable by r-as and resistant to 
SV40 (data not shown). Since CL1 L grew to a lower cell 




FIG. 1. Analysis of SV40 sequences and T antigen expression in 
revertant cell lines. (A) Southern blot analysis. Genomic DNA from 
the four cell lines was digested with /-/pall and BarnHI, electropho- 
resed, and probed with the entire SV40 genome. The lane marked 
3T3/SV40 is a reconstruction in which SV40 genomic DNA was 
mixed with 3T3 genomic DNA and analyzed. 209 represents the 
A209Rl Bl line. The positions of bands corresponding to the early 
and late regions are shown. (B) lmmunoprecipitation analysis. %-la- 
beled proteins were immunoprecipitated with anti-Tantigen hamster 
ascites (ATS) or normal hamster serum (NHS) and analyzed on 8% 
SDS gels. 
density in monolayer culture than CL1 F, indicating the 
tightest growth control, further examination was re- 
stricted to CL1 L. 
Growth parameters of the transformation 
revertant CL1 L 
Additional growth parameters of the CL1 L cell line 
were examined to determine whether other properties 




line SV40” rasa 
3T3 2.5 1.3 
CLlL 0.1 20.0 
CL1 E <O.l 1.4 
CL1 F 0.6 1.7 
FHlB 5.5 6.0 
FH2B 0.5 9.0 
a EOP on preformed 3T3 monolayers is expressed as the number 
of colonies/number of cells plated X 100. 
of CL1 L had also reverted. The morphologies of con- 
fluent monolayers of A209Rl Bl, CL1 L, and 3T3 cells 
are shown in Fig. 2A. A209Rl Bl cells are spindle- 
shaped, rounded, refractile, and grow in a disorgan- 
ized, dense configuration that is typical of transformed 
cells. 3T3 cells are flat, nonrefractile, and form well-or- 
dered monolayers. The morphology of CL1 L cells is 
indistinguishable from that of 3T3 cells. By this crite- 
rion, CL1 L is therefore classified as a revertant. As 
shown in Table 3, the efficiency of plating (EOP) of 
CL1 L cells in soft agar is much more like that of 3T3 
cells than that of A209Rl Bl cells. Photographs of rep- 
resentative fields of soft agar assays in Fig. 2B show 
colonies of CL1 L cells to be slightly greater in size than 
colonies of 3T3 cells (which remained as single cells), 
but much smaller than the colonies of A209Rl Bl cells. 
Even though the CL1 L cell line appears to have some 
capacity to form anchorage-independent colonies, this 
capacity is much less than that of A209Rl Bl cells. 
Therefore, CL1 L has reverted as judged by this param- 
eter. Saturation density in 10% FCS and the ability to 
grow in 1% FCS were also examined (Table 3). Once 
again, CL1 L cells behave like normal cells. Since the 
CL1 L cell line was originally isolated as a serum rever- 
tant, it is especially significant that CL1 L cells do not 
grow in 1% serum. 
Characterization of the CL1 L T antigen 
One possible explanation for the inability of the 
transfected SV40 early region to retransform CL1 L is 
that the T antigen expressed by CL1 L might be defec- 
tive and dominant over the exogenously introduced T 
antigen. Southern blot analysis showed that CL1 L con- 
tains a single copy of the early region (data not shown), 
so we cloned a genomic fragment containing this copy 
into a plasmid vector to create pSVCL1 L. This plasmid, 
or one expressing wild-typeT antigen (pSVB3 or pJYM), 
was transfected into 3T3 cells to assess the relative 
transforming ability of the CL1 L T antigen. pSVCL1 L 
transforms 3T3 cells with at least wild-type efficiency 
as judged by focus formation, ability to grow in soft 
agar, and growth in low serum (Table 4). Indeed, cells 
receiving the CL1 L T antigen had a higher EOP in soft 
agar than cells that received wild-type T antigen. By 
these three criteria, then, the CLlL-encoded large T 
antigen appears to be a fully functional transforming 
protein. 
Transformation resistance of CL1 L 
To more closely examine the transformation resis- 
tance of CL1 L, we infected cells with a retrovirus ex- 
pressing a large T antigen cDNA to efficiently introduce 
T antigen into the cells (Brown et al., 1986). CL1 L and 
3T3 cells were infected with this virus (TEXS) or a con- 
trol virus lacking the T antigen cDNA (SVX), and the 
infected cells were assayed for three growth parame- 
ters (Table 5). The TEXS virus induced anchorage-in- 
dependent growth of 3T3 cells to a significantly higher 
extent than it did of CL1 L cells. This is most clearly 
seen by comparing the relative EOP of TEXS-infected 
cells to that of SVX-infected cells for both cell lines: the 
TEXS EOP:SVX EOP for 3T3 cells is approximately 20 
times higher than that for CL1 L. In addition, the TEXS 
virus induced a significantly larger overall colony size in 
3T3 cells than it did in CL1 L cells and induced many 
microcolonies in 3T3 cells which were not scored as 
positive since they were smaller than colonies of unin- 
fected CL1 L cells (Fig. 3). Thus, the change in the soft 
agar growth phenotype of CL1 L cells after TEXS infec- 
tion is not as great as that observed with 3T3 cells. We 
also examined the behavior of the infected cells in 
focus formation in 5 and 1% serum (Table 5). Again, 
the two cell lines behaved quite differently. TEXS-in- 
fected 3T3 cells formed aggressive foci in monolayers 
in 5% serum which were obvious by 13 days postinfec- 
tion. CL1 L cells infected with TEXS never formed foci in 
monolayer culture, although they did grow to a slightly 
higher density than SVX-infected CL1 L cells. In 1% 
serum, TEXS-infected 3T3 cells formed foci but at a 
level lower than that in 5% serum. No growth of CL1 L 
was observed in 1% serum after infection with either 
the TEXS or the SVX virus. We conclude that although 
soft agar growth of CLlL cells can be increased 
slightly by T antigen, these cells are not capable of 
being fully retransformed. 
Specificity of CL1 L transformation resistance 
To further define the specificity of transformation re- 
sistance, the CL1 L cell line was transfected with a 
small panel of oncogenes: a polyoma middle T antigen 
cDNA (pPyMT1); an activated c-Ha-ras gene (pEJ6.6); 
and a viral src gene (pMvsrc). Transfected cells were 
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3T3 
A209RlBl CLlL 
FIG. 2. Morphology and growth of CL1 L cells. (A) Photographs of confluent monolayers of cells. (B) Photographs of soft agar colonies. 
assayed for growth in soft agar and focus forming abil- 
ity in 5 and lo/o FCS (Table 6). All three oncogenes 
induced the growth of CL1 L cells in soft agar. Soft agar 
colonies of CL1 L cells transfected with middle T and 
v-STC were quite large, showing that CL1 L can exhibit 
the full transformed phenotype in soft agar (Fig. 4). All 
of the plasmids were also able to confer focus forming 
ability on CL1 L in 5% serum, although to various ex- 
tents: the effects on CL1 L of middle T antigen and ras 
were much greater than the effects of v-arc. This differ- 
ence was also seen in lo/o serum assays, where middle 
T antigen and ras induced CL1 L cells to form foci, but 
v-arc did not. 
Binding of T antigen to cellular proteins in CL1 L 
An obvious candidate for a cellular mutation in CL1 L 
would be one of the T antigen-binding proteins which 
have been shown to play a role in SV40 transformation. 
We therefore examined the cellular proteins that are 
bound to large T antigen. CLlL cells or A209RlBl 
cells were metabolically labeled and proteins were iso- 
lated, immunoprecipitated with the anti-T antigen anti- 
body PAb419, and subjected to SDS-PAGE. In precipi- 
tates from both CL1 L and its parental cell line one finds 
p53 and a protein with an approximate molecular 
weight of 120 kDa (Fig. 5). This is probably the plO7/ 
~120 protein that binds to the pRb binding domain of 
large T antigen (Ewen et al., 1989), since a large T 
antigen mutant in this domain does not complex with 
this protein and it does not comigrate with pRb (D.C.K. 
and M.J.I., in press). Although pRb may be present in 
these precipitates just above the T antigen band, ex- 
periments to prove that this is the Rb protein were in- 
conclusive. Nevertheless, there is no obvious defect in 
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TABLE 3 
GROWTH OF CL1 L IN SOFT AGAR AND SATURATION DENSITY 
IN 1 O/O OR 10% SERUM 
Saturation densityb in 
EOP in 
Cell line soft agar” 1 O/O Serum 10% Serum 
A209Rl Bl 3.84 (192) 34.0 x lo4 97 x lo4 
CL1 L 0.04 (2) 4.4 x lo4 15 x lo4 
3T3 <0.02 (0) 3.9 x lo4 13 x lo4 
a EOP is the number of colonies/number of cells plated X 100. The 
number in parentheses is the average number of colonies scored of 
5000 cells plated per dish. 
b Saturation density is the number of cells/cm2. 
binding to proteins known to be involved in SV40 trans- 
formation. 
The phenotype of CL1 L is recessive and defines a 
complementation group 
To determine if the defect in CL1 L is dominant or 
recessive, CL1 L subclones expressing selectable 
markers were fused to normal cells (BALB/c 3T3) or to 
transformed cells (A209Rl Bl) expressing different se- 
lectable markers. Somatic cell hybrids were selected 
and plated into soft agar to test for anchorage-indepen- 
dent growth (Table 7). Fusion of CL1 L to normal 3T3 
cells resulted in hybrids that have a much higher EOP 
than either parental cell line. Some of these hybrid colo- 
nies in soft agar were larger than colonies formed by 
A209Rl Bl, indicating that these fused cells are fully 
transformed. Fusion of CL1 L cells to transformed 
A209Rl Bl cells also resulted in hybrids with an EOP 
greater than that of CL1 L cells and comparable to that 
TABLE 4 
TRANSFORMATION OF BALBk 3T3 CELLS BY THE CL1 L LARGE T ANTIGEN 
Foci inb 





<O.Ol 2 0 
0.29 18 ND 
0.31 ND 25 
0.53 18 24 
Note. The relative transfection efficiencies, as judged by the num- 
ber of G418’ colonies, were comparable for all samples. 
a EOP is as defined in Table 3. Value is average of two to four 
experiments. 
b Average number of foci per loo-mm dish (5% serum) or 60-mm 
dish (1 Oh serum) from two experiments. 
TABLE 5 
GROWTH OF RETROVIRAL INFECTED CELLS IN SOFT AGAR, 
AND Focus FORMATION IN 5% AND 1 O/O SERUM 
Foci in 
Cell line Virus Soft agar 5% Serum 1 ?I0 Serum 
3T3 TEXS 1.35 243 61 
svx 0.006 1 0 
CL1 L TEXS 0.062 0.7 0 
svx 0.005 0 0 
Note. See Table 4 for definitions. Soft agar and 5% serum values 
are averages of three experiments. The 1% serum assay is one ex- 
periment. 
observed when 3T3 cells were fused to transformed 
cells. The defect in CL1 L could be complemented by 
normal cells and does not suppress the phenotype of a 
transformed cell; therefore, it appears to be recessive. 
Fusion of the CL1 L cell line to another T+/tr- cell line, 
A27, was also performed to test for complementation. 
The EOP in soft agar of these hybrids indicates that the 
two cell lines complement each other (Table 7). Fusion 
of each cell line to itself did not result in transformation. 
The CL1 L X A27 hybrids form soft agar colonies that 
are fully transformed, as judged by their size. 
svx TEXS 
FIG. 3. Growth of retroviral-infected cells in soft agar. Soft agar 
colonies of (A) SVX-infected 3T3; (B) TEXS-infected 3T3; (C) SVX-in- 
fected CL1 L; and (D) TEXS-infected CL1 L. 
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TABLE 6 
TRANSFORMATION OF CL1 L BY OTHER ONCOGENES 
Foci in 
Plasmid Soft agar 5% Serum 1 YO Serum 
pSV2neo 0.05 1.2 2.8 
pMvsrc 0.34 29.0 0 
pEJ6.6 0.60 167.3 49.0 
pPyMT1 0.86 312.0 93.5 
Note. See Table 4 for definitions. Soft agar and 5% serum values 
are averages of three to four experiments. The 1% serum values 
represent one to two experiments. 
DISCUSSION 
Expression of SV40 large T antigen in nonpermissive 
ceils triggers cell division and morphological changes 
through its interaction with a number of host factors 
and the subsequent activation or suppression of path- 
ways controlled by these factors (Green, 1989). In the 
present study, we have isolated a cell line, CLlL, 
which appears to carry a recessive mutation in such a 
factor. The evidence for such a mutation is threefold. 
First, CL1 L expresses a T antigen which is fully capa- 
ble of transforming cells, yet CL1 L exhibits the growth 
phenotypes of a normal cell. Second, CL1 L is resistant 
to retransformation by exogenously added large T anti- 
gen but not other representative oncogenes. Third, hy- 
brids formed by fusing CL1 L with either normal or 
transformed cells are themselves transformed. In addi- 
tion, the normal phenotype is stable: rerevertants arise 
at a frequency of 2.5 X 1 Op7, although these cells rarely 
grow as aggressively as the parental cell line, 
A209Rl Bl, when plated in soft agar. 
We examined the function of the T antigen ex- 
pressed in CL1 L by cloning out the single SV40 early 
region from CL1 L and testing its ability to transform 
3T3 fibroblasts. We have extensively mapped the SV40 
sequences in CL1 L and find no evidence for a second 
copy of any part of the early region. Thus, it appears 
that one of the two copies of the early region originally 
present in A209Rl Bl, the parental cell line, was lost 
during isolation of CL1 L. Nonetheless, the CL1 LT anti- 
gen transforms at least as well as wild-type T antigen 
on a molar basis. Although the level of T antigen in 
CLlL is less than that expressed in A209RlB1, it is 
more than sufficient to transform 3T3 cells (G.H.S., 
Ph.D. thesis). In addition, the fact that fusion of CL1 L 
cells to 3T3 cells yields transformed hybrids indicates 
that the CL1 LTantigen is fully functional. Finally, CL1 L 
T antigen is fully capable of forming complexes with 
p53 and ~120. Detection of T antigen-pRb complexes 
in rodent cells has been technically difficult, even in 
cells expressing very high levels of T antigen, in a num- 
ber of laboratories including our own (J.B.C., unpub- 
lished data). We do not think, however, that the defect 
in CL1 L involves pRb, for the following reasons. We 
know that the T antigen in CL1 L can bind pRb since it 
can transform normal cells (Table 4). Thus, one would 
have to argue that the pRb in CL1 L is mutated such 
that it blocks cell growth and is unresponsive to T anti- 
gen. If this were the case, one would expect this unre- 
sponsive pRb to be dominant over wild-type pRb, 
neo PyMT 
FIG. 4. Soft agar growth of oncogene-transfected CL1 L cells. Colonies of cells transfected 
antigen (PyMT), or V-SK are shown. 
with control plasmid (neo), polyomavirus mid1 31e T 
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FIG. 5. T antigen-binding proteins in CL1 L cells. ?Yabeled pro- 
teins from: lane 1, CL1 L immunoprecipitated with PAb419; lane 2, 
A209Rl Bl with pAB419; lane 3, A209Rl Bl with C2-5, an isotype- 
matched control monoclonal specific for herpes simplex virus type 2 
glycoprotein C. The high-molecular-weight band in lane 2 is a non- 
specific band sometimes seen in A209 precipitates. 
which is presumably inactivated when it is bound to T 
antigen (Buchkovich et al., 1989; DeCaprio et al., 
1989). Our data, however, show that fusion of CL1 L to 
normal cells, which express wild-type pRb, results in 
transformation (Table 7). Although this does not for- 
mally rule out a mutation in the Rb gene in CL1 L, the 
possibility of such a mutation is clearly inconsistent 
with current available data. Since evidence does exist 
for an additional host function in SV40 transformation 
(Rutila et al., 1986; Manfredi and Prives, 1990; Yaciuk 
et al., 1991; Michael-Michalovitz et al., 1991), it is pos- 
sible that the mutation in CL1 L may define the gene 
encoding that function. 
When exogenous T antigen is introduced into CL1 L 
by infection with a recombinant retrovirus, growth in 
soft agar is stimulated somewhat, and the cells grow to 
a higher density in monolayers. These retroviral-in- 
fected cells do not, however, form soft agar colonies as 
large as those formed by infected 3T3 cells, nor do 
they form foci in monolayers or grow in low serum. This 
indicates that the mutation in CL1 L differentially affects 
these three parameters of the transformed state, 
namely anchorage independence, loss of contact inhi- 
bition, and serum independence. In addition, the intro- 
duction of exogenous T antigen appears to have an 
effect upon anchorage-independent growth, but the 
infected cells do not form large colonies in soft agar, 
presumably due to the cellular mutation. One possible 
explanation for this is that T antigen might play two 
roles in transformation: (1) stimulating progression 
through the cell cycle and (2) inducing expression of 
the characteristic transformation phenotypes. In this 
model the presence of additional T antigen in CLIL 
might stimulate extra rounds of division but not allow 
the full phenotypic changes which define the trans- 
formed state, perhaps as occurs in abortive transfor- 
mation. A prediction of this model is that other agents 
which stimulate cell division might have the same ef- 
fect. 
The finding that the normal growth phenotype of 
CL1 L is recessive opens the possibility of identifying 
the gene involved by standard DNA transfection proto- 
cols: genomic DNA or cDNA expression libraries from 
transformation-competent cells should be able to 
complement the defect. Although this type of analysis 
requires single-gene defects, the frequency at which 
CL1 L arose, approximately 1 Ow5, indicates that the in- 
volvement of more than one gene is unlikely. More- 
over, although such a frequency appears high for a 
recessive mutation, one must remember that the pa- 
rental cells, being transformed, have likely suffered ex- 
tensive chromosomal loss and rearrangement and 
may therefore be haploid at many loci. Since the pheno- 
type of CL1 L is most striking in low serum, such condi- 
tions should provide a powerful selection in a comple- 
mentation assay. 
TABLE 7 
GROWTH IN SOFT AGAR OF SOMATIC CELL HYBRIDS 
Cells EOP 
A209HymlA 0.98 




A209Neo X A209HymlA 0.76 
CL1 LHym X CL1 LNeo 0.02 
A27Hym 1 B X A27SVX2 0.01 
CL1 LNeo X 3T3Hym4 0.28 
CL1 LNeo X A209HymlA 0.40 
3T3Neo X A209HymlA 0.70 
CL1 LHym X A27SVX2 0.53 
Note. EOP is the number of soft agar colonies/number of cells 
plated X 100. The drug resistance of each cell line is indicated by the 
suffixes Hym and Neo for hygromycin and G418 resistance, respec- 
tively. A27SVX2 is also G418 resistant. 
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A number of groups have studied cell lines in which 
the expression of SV40 T antigen does not correlate 
with the growth phenotype, due to a cellular mutation. 
Pollack and co-workers previously described a number 
of revertant cell lines (Pollack et a/., 1968; Vogel and 
Pollack, 1973; Vogel eT a/., 1973; Vogel and Pollack, 
1974), as did Maruyama et al. (1982). At that time, 
however, tools for molecular analysis were unavail- 
able. More recently, the Graessmann group has identi- 
fied a revertant line, Rev2, which appears to be due to a 
recessive mutation (Bauer et a/., 1987). Studies on tsA 
N-type and A-type transformants, cells expressing a 
temperature-sensitive T antigen which do and do not 
return, respectively, to a normal growth phenotype 
when grown at the nonpermissive temperature, indi- 
cate that the phosphorylation pattern of T antigen cor- 
relates with the growth phenotype (Knippschild et al., 
1991). Specifically, it was found that return to growth 
control was accompanied by a shift to an underphos- 
phorylated form of T antigen in the N-type cells at the 
nonpermissive temperature, whereas the T antigen in 
the A-type cells retained the same phosphorylation 
pattern at both temperatures. This may be significant 
in that it appears that this same underphosphorylated 
form of T antigen has recently been found in Rev2 cells 
(Deppert et al., 1991). It will therefore be of interest to 
examine the phosphotylation of T antigen in CL1 L 
cells. 
The most provocative result of these studies is the 
complementation of the CL1 L and A27 cell lines. This 
indicates that the defects in these two transformation- 
resistant lines fall into separate complementation 
groups. Since A27 cells were isolated under nonselec- 
tive conditions and therefore were never transformed, 
whereas CL1 L is a transformation revertant, it is possi- 
ble that the two cell lines harbor independent muta- 
tions in genes which affect, respectively, establish- 
ment and maintenance of the transformed state. Alter- 
natively, the two defects may relate to the two 
functions proposed for T antigen above. It would be 
interesting to test other revertants in complementation 
assays to obtain an idea of how many host functions 
might be involved in transformation by SV40. The fur- 
ther study of transformation-resistant cell lines such as 
CL1 L and A27 should provide valuable information 
about the pathways involved in SV40-mediated trans- 
formation. 
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